Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber

Journal of the Academy of Nutrition and Dietetics

Volumn 117, Issue 2, 2017, Pages 251-264

  McRorie, Johnson W ^a   McKeown, Nicola M ^a  

^a NONE

Author keywords

Fiber; Health benefits; Insoluble; Misconceptions; Soluble

Indexed keywords

BETA GLUCAN; CHOLESTEROL; GALACTAN; GLUCOSE BLOOD LEVEL; GUAR GUM; INULIN; ISPAGULA; LAXATIVE; MANNAN; PLANT GUM;

ADMINISTRATION AND DOSAGE; BLOOD; CHEMISTRY; DIETARY FIBER; EVIDENCE BASED MEDICINE; FECES; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; RANDOMIZED CONTROLLED TRIAL (TOPIC); VISCOSITY;

BETA-GLUCANS; BLOOD GLUCOSE; CHOLESTEROL; DIETARY FIBER; EVIDENCE-BASED MEDICINE; FECES; GALACTANS; GASTROINTESTINAL TRACT; HUMANS; INULIN; LAXATIVES; MANNANS; PLANT GUMS; PSYLLIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VISCOSITY;

EID: 85008262978     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2016.09.021     Document Type: Article

References (123)

1. 1 Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Energy, Carbohydrates, Fiber, Fat, Fatty Acids Cholesterol, Protein and Amino Acids. 2002, The National Academies Press, Washington, DC.
2. 2 Cummings, J.H., Bingham, S.A., Heaton, K.W., Eastwood, M.A., Fecal weight, colon cancer risk and dietary intake of nonstarch polysaccharides (dietary fiber). Gastroenterology 103:6 (1992), 1783–1789.
3. 3 Franco-Robles, E., López, M., Implication of fructans in health: Immunomodulatory and antioxidant mechanisms. Scientific World J, 2015, 2015, 289267.
4. 4 Seal, C.J., Nugent, A.P., Tee, E.S., Thielecke, F., Whole-grain dietary recommendations: The need for a unified global approach. Br J Nutr 115:11 (2016), 2031–2038.
5. 5 Dehghan, P., Farhangi, M.A., Tavakoli, F., Aliasgarzadeh, A., Akbari, A., Impact of prebiotic supplementation on T-cell subsets and their related cytokines, anthropometric features and blood pressure in patients with type 2 diabetes mellitus: A randomized placebo-controlled trial. Complement Ther Med 24 (2016), 96–102.
6. 6 Law, M., Wald, N., Rudnicka, A., Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis. BMJ 326:7404 (2003), 1423–1429.
7. 7 McRorie, J., Fahey, G., Chapter 8: Fiber supplements and clinically meaningful health benefits: Identifying the physiochemical characteristics of fiber that drive specific physiologic effects. Taylor, C., (eds.) The CRC Handbook on Dietary Supplements in Health Promotion, 2015, CRC Press, Florence, KY.
8. 8 Pereira, D., Gibson, G., Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 37:4 (2002), 259–281.
9. 9 Jackson, K., Taylor, G., Clohessy, A., Williams, C., The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr 82:1 (1999), 23–30.
10. 10 Pedersen, A., Sandstrom, B., Van Amelsvoort, J., The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. Br J Nutr 78:2 (1997), 215–222.
11. 11 Luo, J., Rizkalla, S., Alamowitch, C., et al. Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose. Am J Clin Nutr 63:6 (1996), 939–945.
12. 12 Causey, J., Feirtag, J., Gahaher, D., Tuqland, B., Slavin, J., Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res 20:2 (2000), 191–201.
13. 13 Giaccoa, R., Clementea, G., Luongoa, D., et al. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr 23:3 (2004), 331–340.
14. 14 Alles, M., de Roos, N., Bakx, J., van de Lisdonk, E., Zock, P., Hautvast, J., Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr 69 (1999), 64–69.
15. 15 Letexier, D., Diraison, F., Beylot, M., Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 77:3 (2003), 559–564.
16. 16 Luo, J., Van Yperselle, M., Rizkalla, S., Rossi, F., Bornet, F., Salma, G., Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 130 (2000), 1572–1577.
17. 17 Forcherona, F., Beylot, M., Long-term administration of inulin-type fructans has no significant lipid-lowering effect in normolipidemic humans. Metabolism 56:8 (2007), 1093–1098.
18. 18 de Luis, A., de la Fuente, B., Izaola, O., Aller, R., Gutiérrez, S., Morillo, M., Double blind randomized clinical trial controlled by placebo with a FOS enriched cookie on satiety and cardiovascular risk factors in obese patients. Nutr Hosp 28:1 (2013), 78–85.
19. 19 Dewulf, E., Cani, P., Claus, S., et al. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62:8 (2013), 1112–1121.
20. 20 Parnell, J., Reimer, R., Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. J Clin Nutr 89:6 (2009), 1751–1759.
21. 21 Tovar, A., Caamaño, M., Garcia-Padilla, S., García, O., Duarte, M., Rosado, J., The inclusion of a partial meal replacement with or without inulin to a calorie restricted diet contributes to reach recommended intakes of micronutrients and decrease plasma triglycerides: A randomized clinical trial in obese Mexican women. Nutr J 11 (2012), 44–53.
22. 22 Vulevic, J., Juric, A., Tzortzis, G., Gibson, G., A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 143:3 (2013), 324–331.
23. 23 Davidson, M., Maki, K., Effects of dietary inulin on serum lipids. J Nutr 129:7 suppl (1999), 1474S–1477S.
24. 24 Russo, F., Chimienti, G., Riezzo, G., et al. Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers. Eur J Nutr 47:8 (2008), 453–459.
25. 25 Daubioul, C., Horsmans, Y., Lambert, P., Danse, E., Delzenne, N., Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study. Eur J Clin Nutr 59:5 (2005), 723–726.
26. 26 Wolever, T., Tosh, S., Gibbs, A., Brand-Miller, J., Physicochemical properties of oat β-glucan influence its ability to reduce serum LDL cholesterol in humans: A randomized clinical trial. Am J Clin Nutr 92:4 (2010), 723–732.
27. 27 Kerkhoffs, D., Hornstra, G., Mensick, R., Cholesterol-lowering effect of β-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when β-glucan is incorporated into bread and cookies. Am J Clin Nutr 78:2 (2003), 221–227.
28. 28 Haskell, W., Spiller, G., Jensen, C., Ellis, B., Gates, J., Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am J Cardiol 69:5 (1992), 433–439.
29. 29 Kim, J., Cha, Y.J., Lee, K.H., Park, E., Effect of onion peel extract supplementation on the lipid profile and antioxidative status of healthy young women: A randomized, placebo-controlled, double-blind, crossover trial. Nutr Res Pract 7:5 (2013), 373–379.
30. 30 Vuksan, V., Jenkins, A., Rogovik, A., Fairgrieve, C., Jovanovski, E., Leiter, L., Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals. Br J Nutr 106 (2011), 1349–1352.
31. 31 McRorie, J., Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 1: What to look for and how to recommend an effective fiber therapy. Nutr Today 50:2 (2015), 82–89.
32. 32 Ribas, S., Cunha, D., Sichieri, R., da Silva, L., Effects of psyllium on LDL-cholesterol concentrations in Brazilian children and adolescents: A randomised, placebo-controlled, parallel clinical trial. Br J Nutr 113:1 (2015), 134–141.
33. 33 Anderson, J., Allgood, L., Lawrence, A., et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr 71:2 (2000), 1472–1479.
34. 34 Anderson, J., Floore, T., Geil, P., Spencer, D., Balm, T., Hypocholesterolemic effects of different bulk-forming hydrophilic fibers as a adjuncts to dietary therapy in mild to moderate hypercholesterolemia. Arch Intern Med 151:8 (1991), 1597–1602.
35. 35 Olson, B., Anderson, S., Becker, M., et al. Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: Results of a meta-analysis. J Nutr 127:10 (1997), 1973–1980.
36. 36 Anderson, J., Zettwoch, N., Feldman, T., Tietyen-Clark, J., Oeltgen, P., Bishop, C., Cholesterol-lowering effects of psyllium hydrophilic mucilloid for hypercholetserolemic men. Arch Intern Med 148:2 (1998), 292–296.
37. 37 Gupta, R., Agrawal, C., Singh, G., Ghatak, A., Lipid-lowering efficacy of psyllium hydrophilic mucilloid in non-insulin dependent diabetes mellitus with hyperlipidemia. Indian J Med Res 100 (1994), 237–241.
38. 38 Cicero, A., Derosa, G., Bove, M., Imola, F., Borghi, C., Gaddi, A., Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet. Mediterr J Nutr Metab 3 (2010), 47–54.
39. 39 Rodriguez-Moran, M., Guerrero-Romero, F., Laczano-Burciaga, L., Lipid- and glucose-lowering efficacy of plantago psyllium in type II diabetes. J Diabetes Complicat 12:5 (1998), 273–278.
40. 40 Anderson, J., Allgood, L., Turner, C., Oelgten, P., Daggy, B., Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 70:4 (1999), 466–473.
41. 41 Jenkins, D., Wolever, T., Vidgen, E., et al. Effect of psyllium in hypercholesterolemia at two monounsaturated fatty acid intakes. Am J Clin Nutr 65:5 (1997), 1524–1533.
42. 42 Everson, G., Daggy, B., McKinley, C., Story, J., Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men. J Lipid Res 33:8 (1992), 1183–1192.
43. 43 Levin, E., Miller, V., Muesing, R., Stoy, D., Balm, T., LaRosa, J., Comparison of psyllium hydrophilic mucilloid and cellulose as adjuncts to a prudent diet in the treatment of mild to moderate hypercholesterolemia. Arch Intern Med 150:9 (1990), 1822–1827.
44. 44 Stoy, D., LaRosa, J., Brewer, B., Mackey, M., Meusing, R., Cholesterol-lowering effects of ready-to-eat cereal containing psyllium. J Am Diet Assoc 93:8 (1993), 910–912.
45. 45 Sprecher, D., Harris, B., Goldberg, A., Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- and low-fat diets. Ann Intern Med 119:pt 1 (1993), 545–554.
46. 46 Summerbell, C., Manley, P., Barnes, D., Leeds, A., The effects of psyllium on blood lipids in hypercholesterolaemic subjects. J Hum Nutr Diet 7 (1994), 147–151.
47. 47 Bell, L., Hectorne, K., Reynolds, H., Balm, T., Hunninghake, D., Cholesterol-lowering effects of psyllium hydrophilic mucilloid: Adjunct therapy to a prudent diet for patients with mild to moderate hypercholesterolemia. JAMA 261:23 (1989), 3419–3423.
48. 48 Bell, L., Hectorn, K., Reynolds, H., Hunninghake, D., Cholesterol-lowering effects of soluble-fiber cereals as part of a prudent diet for patients with mild to moderate hypercholesterolemia. Am J Clin Nutr 52:6 (1990), 1020–1026.
49. 49 Weingand, K., Le, N., Kuzmak, B., et al. Effects of psyllium on cholesterol and low-density lipoprotein. Endocrinol Metab 4 (1997), 141–150.
50. 50 de Bock, M., Derraik, J., Brennan, C., et al. Psyllium supplementation in adolescents improves fat distribution and lipid profile: A randomized, participant-blinded, placebo-controlled, crossover trial. PLoS ONE, 7(7), 2012, e41735.
51. 51 Romero, A., Romero, J., Galaviz, S., Fernandez, M., Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern Mexico. J Am Coll Nutr 17:6 (1998), 601–608.
52. 52 Shrestha, S., Freake, H., McGrane, M., Volek, J., Fernandez, M., A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake. J Nutr 137:5 (2007), 1165–1170.
53. 53 Shrestha, S., Volek, J., Udani, J., et al. A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals. J Nutr 136:10 (2006), 2492–2497.
54. 54 Neal, G., Balm, T., Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia. South Med J 83:10 (1990), 1131–1137.
55. 55 Moreyra, A., Wilson, A., Koraym, A., Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Int Med 165:10 (2005), 1161–1166.
56. 56 Maciejko, J., Brazg, R., Shah, A., Patil, S., Rubenfire, M., Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia. Arch Fam Med 3:11 (1994), 955–960.
57. 57 Spence, J., Huff, M., Heidenheim, P., Viswanatha, A., Munoz, C., Lindsay, R., Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia. Ann Intern Med 123:7 (1995), 493–499.
58. 58 Agrawal, A., Tandon, M., Sharma, P., Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Int J Clin Pract 61:11 (2007), 1812–1818.
59. 59 Jayaram, S., Prasad, H., Sovani, V., Langade, D., Mane, P., Randomized study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia. J Indian Med Assoc 105:3 (2007), 142–145.
60. 60 Code of Federal Regulations, Title 21. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=101.81 Accessed March 6, 2015.
61. 61 Jenkins, D., Wolever, T., Leeds, A., Gassull, M., Haisman, P., Dilawari, J., Dietary fibres, fibre analogues, and glucose tolerance: Importance of viscosity. BMJ 1 (1978), 1392–1394.
62. 62 Ziai, S., Larijani, B., Akhoondzadeh, S., Fakhzadeh, H., Dastpak, A., Bandarian, F., Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol 102 (2005), 202–207.
63. 63 Feinglos, M., Gibb, R., Ramsey, D., Surwit, R., McRorie, J., Psyllium improves glycemic control in patients with type-2 diabetes mellitus. Bio Carb Dietary Fibre 1 (2013), 156–161.
64. 64 Dall'Alba, V., Silva, F.M., Antonio, J.P., et al. Improvement of the metabolic syndrome profile by soluble fibre—guar gum—in patients with type 2 diabetes: A randomised clinical trial. Br J Nutr 110:9 (2013), 1601–1610.
65. 65 Maljaars, P., Peters, H., Mela, D., Masclee, A., Ileal brake: A sensible food target for appetite control. A review. Physiol Behav 95 (2008), 271–281.
66. 66 Kawasaki, N., Suzuki, Y., Urashima, M., et al. Effect of gelatinization on gastric emptying and absorption. Hepatogastroenterol 55:86-87 (2008), 1843–1845.
67. 67 Gibb, R., McRorie, J., Russell, D., Hasselblad, V., D'Alessio, D., Psyllium fiber improves glycemic control proportional to loss of glycemic control: A meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr 102:6 (2015), 1604–1614.
68. 68 McRorie, J., Pepple, S., Rudolph, C., Effects of fiber laxatives and calcium docusate on regional water content and viscosity of digesta in the large intestine of the pig. Dig Dis Sci 43:4 (1998), 738–745.
69. 69 McRorie, J., Daggy, B., Morel, J., Diersing, P., Miner, P., Robinson, M., Psyllium is superior to docusate sodium for treatment of chronic constipation. Aliment Pharm Ther 12 (1998), 491–497.
70. 70 McRorie, J., Zorich, N., Riccardi, K., Bishop, L., Filloon, T., Wason, S., Giannella, R., Effects of Olestra and sorbitol consumption on objective measures of diarrhea: Impact of stool viscosity on common gastrointestinal symptoms. Reg Tox Pharm 31:1 (2000), 59–67.
71. 71 Slavin, J., Feirtag, J., Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects. Food Funct 2 (2011), 72–77.
72. 72 Costabile, A., Fava, F., Roytio, H., et al. Impact of polydextrose on the faecal microbiota: A double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Br J Nutr 108 (2012), 471–481.
73. 73 Costabile, A., Kolida, S., Klinder, A., et al. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr 104 (2010), 1007–1017.
74. 74 van Dokkum, W., Wezendonk, B., Srikumar, T., van den Heuvel, E., Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects. Eur J Clin Nutr 53:1 (1999), 1–7.
75. 75 Ramnani, P., Gaudier, E., Bingham, M., van Bruggen, P., Tuohy, K., Gibson, G., Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: A human intervention study. Br J Nutr 104:2 (2010), 233–240.
76. 76 Kleessen, B., Schwarz, S., Boehm, A., et al. Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Br J Nutr 98:3 (2007), 540–549.
77. 77 Waitzberg, L., Pereira, A., Logullo, L., et al. Microbiota benefits after inulin and partially hydrolized guar gum supplementation: A randomized clinical trial in constipated women. Nutr Hosp 27:1 (2012), 123–129.
78. 78 Marteau, P., Jacobs, H., Cazabiel, M., Signoret, C., Prevel, J., Housez, B., Effects of chicory inulin in constipated elderly people: A double-blind controlled trial. Int J Food Sci Nutr 62:2 (2011), 164–170.
79. 79 Dahl, W., Whiting, S., Isaac, T., Weeks, S., Arnold, C., Effects of thickened beverages fortified with inulin on beverage acceptance, gastrointestinal function, and bone resorption in institutionalized adults. Nutr 21:3 (2005), 308–311.
80. 80 Den Hand, E., Geypens, B., Ghoos, Y., Effect of high performance chicory inulin on constipation. Nutr Res 20:5 (2000), 731–736.
81. 81 Boler, B., Serao, M., Bauer, L., et al. Digestive physiological outcomes related to polydextrose and soluble corn fibre consumption by healthy adult men. Br J Nutr 106 (2011), 1864–1871.
82. 82 Stewart, M., Nikhanj, S., Timm, D., Thomas, W., Slavin, J., Evaluation of the effect of four fibers on laxation, gastrointestinal tolerance and serum markers in healthy humans. Ann Nutr Metab 56 (2010), 91–98.
83. 83 Timm, D., Thomas, W., Boileau, T., Williamson-Hughes, P., Slavin, J., Polydextrose and soluble corn fiber increase five-day fecal weight in healthy men and women. J Nutr 143 (2013), 473–478.
84. 84 van den Heuvel, E., Wils, D., Pasman, W., Saniez, M., Kardinaal, A., Dietary supplementation of different doses of NUTRIOSE-FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men. Eur J Nutr 44 (2005), 445–451.
85. 85 van den Heuvel, E., Wils, D., Pasman, W., Bakker, M., Saniez, M., Kardinaal, A., Short-term digestive tolerance of different doses of NUTRIOSE FB, a food dextrin, in adult men. Eur J Clin Nutr 58:7 (2004), 1046–1055.
86. 86 Jie, Z., Bang-Yao, L., Ming-Jie, X., Hai-Wei, L., Zu-Kang, Z., Ting-Song, W., Craig, S., Studies on the effects of polydextrose intake on physiologic functions in Chinese people. Am J Clin Nutr 72 (2000), 1503–1509.
87. 87 Hengst, C., Ptok, S., Roessler, A., Fechner, A., Jahreis, G., Effects of polydextrose supplementation on different fecal parameters in healthy volunteers. Int J Food Sci Nutr 60:suppl 5 (2009), 96–105.
88. 88 Hamilton, J., Wagner, J., Burdick, B., Bass, P., Clinical evaluation of methylcellulose as a bulk laxative. Dig Dis Sci 33:8 (1988), 993–998.
89. 89 Slavin, J., Savarino, V., Paredes-Diaz, A., Fotopoulos, G., A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res 37:1 (2009), 1–17.
90. 90 Taghipoor, M., Barles, G., Georgelin, C., Licois, J., Lescoat, P., Digestion modeling in the small intestine: Impact of dietary fiber. Math Biosci 258 (2014), 101–112.
91. 91 Mudgil, D., Barak, S., Composition, properties and health benefits of indigestible carbohydrate polymers as dietary fiber: A review. Int J Biol Macromol 61 (2013), 1–6.
92. 92 McRorie, J., Evidence-based approach to fiber supplements and clinically meaningful health benefits, part 2: What to look for and how to recommend an effective fiber therapy. Nutr Today 50:2 (2015), 90–97.
93. 93 Brodribb, A., Groves, C., Effect of bran particle size on stool weight. Gut 19:1 (1978), 60–63.
94. 94 Tomlin, J., Read, N., Laxative properties of indigestible plastic particles. BMJ 297 (1988), 1175–1176.
95. 95 Lewis, S., Heaton, K., The intestinal effects of bran-like plastic particles: Is the concept of ‘roughage’ valid after all?. Eur J Gastroenterol Hepatol 9:6 (1997), 553–557.
96. 96 Lewis, S., Heaton, K., Roughage revisited: The effect on intestinal function of inert plastic particles of different sizes and shapes. Dig Dis Sci 44 (1999), 744–748.
97. 97 Wrick, K., Robertson, J., von Soest, P., et al. The influence of dietary fiber source on human intestinal transit and stool output. J Nutr 113 (1983), 1464–1479.
98. 98 Francis, C., Whorwell, P., Bran and irritable bowel syndrome: Time for reappraisal. Lancet 344 (1994), 39–40.
99. 99 Eswaran, S., Muir, J., Chey, W., Fiber and functional gastrointestinal disorders. Am J Gastroenterol 108 (2013), 718–727.
100. 100 Wolever, T., Robb, P., Effect of guar, pectin, psyllium, soy polysaccharide and cellulose on breath hydrogen and methane in healthy subjects. Am J Gastroenterol 87 (1992), 305–310.
101. 101 Lampe, J., Effertz, M., Larson, J., Slavin, J., Gastrointestinal effects of modified guar gum and soy polysaccharide as part of an enteral formula diet. J Parenter Enteral Nutr 16:6 (1992), 538–544.
102. 102 Chen, H., Haack, V., Janecky, C., Vollendorf, N., Marlett, J., Mechanisms by which wheat bran and oat bran increase stool weight in humans. Am J Clin Nutr 68 (1998), 711–719.
103. 103 Spencer, H., Norris, C., Derler, J., Osis, D., Effect of oat bran muffins on calcium absorption and calcium, phosphorus, magnesium and zinc balance in men. J Nutr 121 (1991), 1976–1983.
104. 104 Kirby, R., Anderson, J., Sieling, B., et al. Oat-bran intake selectively lowers serum low density lipoprotein cholesterol concentrations of hypercholesterolemic men. Am J Clin Nutr 34 (1981), 824–829.
105. 105 McRorie, J., Clinical data support that psyllium is not fermented in the gut. [letter to the Editor] Am J Gastroenterol, 108(9), 2013, 1541.
106. 106 Vega, A., Perelló, A., Martos, L., et al. Breath methane in functional constipation: Response to treatment with ispaghula husk. Neurogastroenterol Motil 27 (2015), 945–953.
107. 107 Chaplin, M., Chaudhury, S., Dettmar, P., Sykes, J., Shaw, A., Davies, G., Effect of ispaghula husk on the faecal output of bile acids in healthy volunteers. J Steroid Biochem Mol Biol 72:5 (2000), 283–292.
108. 108 Ashraf, W., Park, F., Lof, J., Quigley, E., Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation. Aliment Pharmacol Ther 9:6 (1995), 639–647.
109. 109 Brandt, L., Prather, C., Quigley, E., Schiller, L., Schoenfeld, P., Talley, N., Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 100:suppl (2005), S5–S22.
110. 110 Ford, A., Moayyedi, P., Lacy, B., et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol 109:suppl (2014), S2–S26.
111. 111 Bijkerk, C., de Wit, N., Muris, J., Whorwell, P., Knottnerus, J., Hoes, A., Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. Br Med J, 339, 2009;27, b3154.
112. 112 Qvitzau, S., Matzen, P., Madsen, P., Treatment of chronic diarrhoea: Loperamide versus ispaghula husk and calcium. Scand J Gastroenterol 23 (1988), 1237–1240.
113. 113 Wenzl, H., Fine, K., Schiller, L., Fordtran, J., Determinants of decreased fecal consistency in patients with diarrhea. Gastroenterol 108:6 (1995), 1729–1738.
114. 114 Washington, N., Harris, M., Mussellwhite, A., Spiller, R., Moderation of lactulose-induced diarrhea by psyllium: Effects on motility and fermentation. Am J Clin Nutr 67 (1998), 317–321.
115. 115 Fujimori, S., Tatsuguchi, A., Gudis, K., et al. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. J Gastroenterol Hepatol 22:8 (2007), 1199–1204.
116. 116 Eherer, A., Santa Ana, C., Fordtran, J., Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein. Gastroenterology 104 (1993), 1007–1012.
117. 117 Prior, A., Whorwell, P., Double blind study of ispaghula in irritable bowel syndrome. Gut 28:11 (1987), 1510–1513.
118. 118 Kumar, A., Kumar, N., Vij, J., Sarin, S., Anand, B., Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: Correlation of symptom relief with whole gut transit time and stool weight. Gut 28:2 (1987), 150–155.
119. 119 McRorie, J., Greenwood-Van Meerveld, B., Rudolph, C., Characterization of propagating contractions in the proximal colon of ambulatory mini pigs. Dig Dis Sci 43:5 (1998), 957–963.
120. 120 Bassotti, G., Crowell, M., Whitehead, W., Contractile activity of the human colon: Lessons from 24 hour studies. Gut 34:1 (1993), 129–133.
121. 121 Bassotti, G., Iantorno, G., Fiorella, S., Bustos-Fernandez, L., Bilder, C., Colonic motility in man: Features in normal subjects and in patients with chronic idiopathic constipation. Am J Gastroenterol 94:7 (1999), 1760–1770.
122. 122 Greenwood-van Meerveld, B., Neeley, D., Tyler, K., Peters, L., McRorie, J., Comparison of effects on colonic motility and stool characteristics associated with feeding Olestra and wheat bran to ambulatory mini-pigs. Dig Dis Sci 44:7 (1999), 1282–1287.
123. 123 Brandt, L.J., Prather, C.M., Quigley, E.M., Schiller, L.R., Schoenfeld, P., Talley, N.J., Systematic review on the management of chronic constipation in North America. Am J Gastroenterol 100:suppl 1 (2005), S5–S22.